Medallion Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$107K Hold
510
– – 0.03% 335
2026
Q2
$97K Hold
510
– – 0.03% 354
2026
Q1
$86.1K Hold
510
– – 0.03% 384
2025
Q4
$86.1K Hold
510
– – 0.03% 377
2025
Q3
$73.6K Hold
510
– – 0.03% 403
2025
Q2
$65.1K Hold
510
– – 0.03% 417
2025
Q1
$63.5K Hold
510
– – 0.03% 382
2024
Q4
$67.4K Buy
+510
New +$71.7K 0.03% 361

Other funds holding IBB

Medallion Wealth Advisors's IBB Position: Q3 2026 in Review

Medallion Wealth Advisors held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 510 shares worth $107K. The position accounts for 0.03% of the portfolio, ranked #335.

Medallion Wealth Advisors first reported a position in IBB in Q4 2024 and has held it in 8 quarters since. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Medallion Wealth Advisors held 510 shares of iShares Biotechnology ETF worth $107K as of Q3 2026.
  • Medallion Wealth Advisors left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.03% of Medallion Wealth Advisors's portfolio in Q3 2026, its #335 holding.
  • Medallion Wealth Advisors first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 8 quarters since.
  • 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Medallion Wealth Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.